James Treat, M.D.

Professor of Clinical Pediatrics (General Pediatrics)
Attending Dermatologist, Children's Hospital of Philadelphia
Education Director, Pediatric Dermatology, Children's Hospital of Philadelphia, University of Pennsylvania
Fellowship Director, Pediatric Dermatology, Children's Hospital of Philadelphia, University of Pennsylvania
Department: Pediatrics
Contact information
University of Pennsylvania, Perelman School of Medicine
Children's Hospital of Philadelphia
HUB 6581
34th and Civic Center Blvd
Philadelphia, PA 19104
215-590-2169
Philadelphia, PA 19104
Children's Hospital of Philadelphia
HUB 6581
34th and Civic Center Blvd
Philadelphia, PA 19104
215-590-2169
Philadelphia, PA 19104
Office: 215-590-2159
Fax: 215-590-4948
Fax: 215-590-4948
Education:
BA (Biological Basis of Behavior, minor Anthropology )
University of Pennsylvania, 1997.
MD
University of Pennsylvania, 2002.
Permanent linkBA (Biological Basis of Behavior, minor Anthropology )
University of Pennsylvania, 1997.
MD
University of Pennsylvania, 2002.
Description of Clinical Expertise
HemangiomasCapillary Malformations (Port Wine Stains)
Acne
Atopic Dermatitis
Birthmarks
Allergic Contact Dermatitis
Dermatologic manifestations of infectious diseases
Genodermatoses
Melanocytic Nevi
Molluscum
Pigmentary Anomalies
Pediatric Dermatology
Warts
Selected Publications
Palepu S, Treat JR.: Presumed Trichophyton indotineae Infection in Children: A Call for Heightened Clinical Awareness. Pediatr Dermatol Online ahead of print, Mar 2025.Zarowin DH, Buros Stein A, Sheppard SE, Treat JR.: A Retrospective Review of Oral N-Acetylcysteine for Habit-Driven Cutaneous Disorders. Pediatr Dermatol Jan 2025.
Banbury S, Milgraum DM, Lewis DJ, Queenan M, Treat JR. : Post-streptococcal small-vessel vasculitis in a 16-month-old with associated intussusception and hypertension: Henoch Schönlein purpura? Pediatr Dermatol. 41(5): 929-931, Sep-Oct 2024.
Berna R, Hasbun T, Adams D, Moon AT, Treat JR. : Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib. Pediatr Dermatol. 41(5): 936-937, Sep-Oct 2024.
Braun M, Frieden IJ, Siegel DH, George E, Hess CP, Fox CK, Chamlin SL, Drolet BA, Metry D, Pope E, Powell J, Holland K, Ulschmid C, Liang MG, Barry KK, Ho T, Cotter C, Baselga E, Bosquez D, Jain SN, Bui JK, Lara-Corrales I, Funk T, Small A, Baghoomian W, Yan AC, Treat JR, Hogrogian GS, Huang C, Haggstrom A, List M, McCuaig CC, Barrio V, Mancini AJ, Lawley LP, Grunnet-Satcher K, Horii KA, Newell B, Nopper A, Garzon MC, Scollan ME, Mathes EF. : Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10. J Pediatr 267(113907), Apr 2024.
Ricles VR, Treat JR. : Tinea Versicolor in an Infant. J Pediatr. 267(113920), Apr 2024.
Netravali IA, Sockler PG, Heimall J, Treat JR. : Rapid resolution of diffuse warts following initiation of dupilumab for severe atopic dermatitis. Pediatr Dermatol. 41(2): 275-278, Mar-Apr 2024.
Ahmed F, Do N, Vanderver AL, Treat JR. : Dyschromatosis symmetrica hereditaria: A clue to early diagnosis of Aicardi-Goutières syndrome. Pediatr Dermatol. 41(1): 156-157, Jan-Feb 2024.
Nriagu BN, Williams LS, Brewer N, Surrey LF, Srinivasan AS, Li D, Britt A, Treat J, Crowley TB, O'Connor N, Ganguly A, Low D, Queenan M, Drivas TG, Zackai EH, Adams DM, Hakonarson H, Snyder KM, Sheppard SE. : Microcystic lymphatic malformations in Turner syndrome are due to somatic mosaicism of PIK3CA. Am J Med Genet A. 194(1): 64-69, Jan 2024.
Zendt M, Bustos Carrillo FA, Kelly S, Saturday T, DeGrange M, Ginigeme A, Wu L, Callier V, Ortega-Villa A, Faust M, Chang-Rabley E, Bugal K, Kenney H, Khil P, Youn JH, Osei G, Regmi P, Anderson V, Bosticardo M, Daub J, DiMaggio T, Kreuzburg S, Pala F, Pfister J, Treat J, Ulrick J, Karkanitsa M, Kalish H, Kuhns DB, Priel DL, Fink DL, Tsang JS, Sparks R, Uzel G, Waldman MA, Zerbe CS, Delmonte OM, Bergerson JRE, Das S, Freeman AF, Lionakis MS, Sadtler K, van Doremalen N, Munster V, Notarangelo LD, Holland SM, Ricotta EE. : Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies. Sci Adv 9(41), Oct 2023.